Nuclear <scp>DUX4 immunohistochemistry</scp> is a <scp>highly sensitive</scp> and <scp>specific marker</scp> for the <scp>presence</scp> of <scp><i>CIC</i></scp>::<scp><i>DUX4</i></scp> fusion in <scp>CIC</scp>‐rearranged <scp>sarcomas</scp>: a <scp>study</scp> of 48 <scp>molecularly confirmed cases</scp>

Abstract

DUX4 IHC is a highly sensitive and specific surrogate marker for the presence of CIC::DUX4 fusion, demonstrating its utility in establishing a diagnosis of CRS.